Titled "The Potential of Fasting and Diet in the Future of Medicine" Highlighting the Potential of ...
DENVER, Aug. 27, 2025 /PRNewswire/ -- Cerecin, a global biotech company focused on neurometabolism,...
Cerecin and IMCB signed a Memorandum of Understanding to collaborate in the areas of neurometabolis...
* Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for ...
* Data from the pilot study in infantile spasms showed positive outcomes. * The results will be ...
* Data from the pilot study in infantile spasms showed positive outcomes. * The results will be ...
* A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated fo...